Congress of the European-Society-of-Cardiology (ESC) Conference

related documents

• Adherence to anticoagulant treatment with apixaban and rivaroxaban in a real-world setting  Conferences
• An evaluation of the incidence and prognosis of post coronary artery bypass grafting myocardial infarction according to different definitions in the CORONARY trial  Conferences
• An event driven myocardial infarction definition using troponins after coronary artery bypass surgery in the coronary trial  Conferences
• Antithrombotic therapy for stroke prevention in patients with newly diagnosed atrial fibrillation and a history of acute coronary syndrome: the Global Anticoagulant Registry in the FIELD (GARFIELD)  Conferences
• Application of syncope guidelines in the emergency department do not reduce admission rates: a retrospective cohort study  Conferences
• Association of urinary sodium excretion with blood pressure and cardiovascular clinical events in South America: The PURE study  Conferences
• Associations of hemodynamic load with impaired myocardial flow reserve: role of sex and hypertension  Conferences
• Atrial fibrillation post myocardial infarction is associated with ventricular fibrillation and poor long term out come  Conferences
• Biventricular dysfunction following administration of anthracycline based chemotherapy in breast cancer: a prospective multi-centre study using advanced cardiac imaging and biochemical markers  Conferences
• Cancer, chronic kidney disease and thrombosis  Conferences
• Cardiac biomarkers and left ventricular hypertrophy in relation to outcomes in patients with atrial fibrillation: experiences from the RELY trial  Conferences
• Changes in BNP prior to major cardiovascular events in patients with type 2 diabetes and a recent coronary event  Conferences
• Changes in NT-proBNP level after successful PVC ablation in patients without structural heart disease: evidence for PVC-induced chronic wall stress  Conferences
• Changes in left ventricular twist during dobutamine stress echocardiography in patients with myocardial infarction: association with left ventricular reverse remodeling  Conferences
• Clinical outcomes of atrial fibrillation patients receiving NSAIDs in the RE-LY trial  Conferences
• Community health worker based interventions in secondary prevention of CVD in India (SPREAD): methods and baseline results  Conferences
• Comparative effectiveness of transitional care services in patients discharged from hospital with heart failure: a meta-analysis  Conferences
• Effect of apixaban on all-cause mortality in atrial fibrillation: an imputed placebo analysis  Conferences
• Effects of n-3 fatty acids on long-term outcomes of high risk patients with type 2 diabetes mellitus or IGF/IGT with a recent myocardial infarction  Conferences
• Efficacy and safety of different bridging regimens of parenteral anticoagulation after mechanical valve replacement  Conferences
• Evidence based medication use is highly predictive of survival in heart failure patients in Africa, Asia, the Middle East and South America: the INTERCHF Study  Conferences
• Evolving antithrombotic treatment patterns in patients with newly diagnosed atrial fibrillation in GARFIELD-AF  Conferences
• Experience with tecarfarin, a novel vitamin K antagonist: use with reversing agents and in mechanical heart valve recipients  Conferences
• Finding cardiac abnormalities in family members of cardiac arrest or sudden death victims through comprehensive clinical and genetic screening: results from the CASPER registry  Conferences
• Growth differentiation factor 15 is an independent marker of risk of major bleeding in atrial fibrillation: insights from the RE-LY trial  Conferences
• Guidance adherent dabigatran etexilate treatment versus warfarin in the RE-LY population: an analysis on the basis of the European label recommendations for dabigatran etexilate  Conferences
• Hypertension and age-specific burden of carotid atherosclerosis in China: results from 25,000 individuals in the China Kadoorie biobank study  Conferences
• Identification of blood CSF1 and CXCL12 as new causal mediators of coronary artery disease using Mendelian randomization in the ORIGIN trial  Conferences
• Impact of renal function on use of antithrombotic therapy in atrial fibrillation: real-world perspective from the global anticoagulant registry in the FIELD registry  Conferences
• Impact of weight reduction on pericardial fat volume and cardiac structure: Implications for atrial fibrillation in a randomized clinical trial  Conferences
• Influence of hospitalization for cardiovascular versus noncardiovascular reasons on subsequent mortality in patients with chronic heart failure across the spectrum of ejection fraction  Conferences
• Influence of socioeconomic status on Acute Myocardial Infarction (AMI) in China population: the Interheart China study  Conferences
• Initial experience with idarucizumab in dabigatran-treated patients requiring emergency surgery or interventon: interim results from the RE-VERSE AD study  Conferences
• Interobserver variability of the SYNTAX score by interventional cardiologists  Conferences
• Is extraplatelet production of thromboxane B2 in acute myocardial infarction the explanation for higher rates of adverse cardiovascular events?  Conferences
• Left atrial strain relates to surgical indication in patients with severe organic mitral regurgitation: a 2D-speckle tracking study  Conferences
• Left ventricular dyssynchrony induced by chronic right ventricular pacing is associated with long-term poor outcome  Conferences
• Lifestyle risk factors for non-valvular atrial fibrillation  Conferences
• Long term outcomes of PCI and CABG for isolated proximal LAD lesions: a real world comparison  Conferences
• Management of dyspepsia symptoms on dabigatran during RELY-ABLE: long-term follow up study after RE-LY  Conferences
• Maternal cardiovascular effects of placental dysfunction in the 2nd trimester  Conferences
• Mitral valve morphological abnormalities in severe aortic stenosis - a three-dimensional transesophageal echocardiographic study  Conferences
• Net clinical benefit of apixaban among patients with atrial fibrillation  Conferences
• New insights into the role of thyroid hormones in the severity of right ventricular dysfunction  Conferences
• Observational monocentric registry "CARDIO-STEMI SANREMO": effects of morphine administration in STEMI patients and its association with clinical in-hospital outcomes and long-term mortality  Conferences
• One-year outcomes in new versus permanent atrial fibrillation: insights from the prospective, international GARFIELD registry  Conferences
• Phased array pulmonary vein isolation vs radiofrequency catheter ablation for atrial fibrillation: a non-inferiority systematic review and meta-analysis  Conferences
• Physical activity levels, sport activities and risk of acute myocardial infarction: results of the INTERHEART study in China  Conferences
• Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation  Conferences
• Predictors of major bleeding in patients with atrial fibrillation treated with rivaroxaban in XANTUS: findings from a real-world prospective study  Conferences
• Prognostic importance of precipitating factors leading to heart failure hospitalization in patients with preserved and reduced ejection fraction: Insights from CHARM  Conferences
• Prognostic value of electrocardiographic left ventricular hypertrophy in patients with atrial fibrillation  Conferences
• Progression to asymptomatic atrial fibrillation as a prognostic index: the Euro Heart Study  Conferences
• Randomized trial to examine the effect of ASA dose or ASA dosing frequency on ASA resistance after coronary artery bypass graft surgery  Conferences
• Real world usage of direct oral anticoagulants in patients undergoing electrical cardioversion for atrial tachyarrhythmias  Conferences
• Reduction in unnecessary ventricular pacing fails to affect hard clinical outcomes: A meta-analysis  Conferences
• Regional differences in the use of antithrombotic therapy for stroke prevention in atrial fibrillation: European and Asian insights from the Global Anticoagulant Registry in the FIELD (GARFIELD)  Conferences
• Renal transplant patients have impaired myocardial perfusion independent of the degree of left ventricular hypertrophy: a CMR study  Conferences
• Resting heart rate and decline in cognitive function: observations from the ONTARGET/TRANSCEND studies  Conferences
• Reversal strategies and outcomes of major bleeding associated with direct oral anticoagulants compared to warfarin in routine practice: interim results from a multi-centre all-comer cohort  Conferences
• Safety and efficacy of angio-seal vs exo-seal in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction  Conferences
• Sedation with sevoflurane improves reperfusion in acute myocardial infarction  Conferences
• Segmental myocardial viability assessment after STEMI: myocardial grid-tagging versus late gadolinium-enhanced magnetic resonance imaging  Conferences
• Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for novel oral anticoagulant dose adjustment  Conferences
• Stroke, major bleeding and mortality in newly diagnosed atrial fibrillation with moderate-to-severe chronic kidney disease: results from GARFIELD-AF  Conferences
• Subgroup analysis of patients with concomitant pulmonary embolism in XALIA, a non-interventional study of rivaroxaban in routine treatment of deep vein thrombosis  Conferences
• Surgical ablation of atrial fibrillation ablation in 11 countries: the LAAOS III trial  Conferences
• The prognostic values of hypoalbuminemia in patients with ST-segment elevation myocardial infarction  Conferences
• Thromboxane B2 as a predictor of long-term outcomes in acute myocardial infarction  Conferences
• Troponin T or I levels following ICD implantation with and without defibrillation testing and their predictive value for outcomes: Insights from the SIMPLE trial  Conferences
• Twelve-month outcomes in paroxysmal versus permanent atrial fibrillation: data from the prospective, international GARFIELD registry  Conferences
• Vitamin K antagonist control for patients with nonvalvular atrial fibrillation in Eastern and Southeastern Asia: an analysis of event rates from GARFIELD-AF  Conferences
• Women with stable coronary artery disease have better clinical outcomes than men, but this association is modified by degree of depression: insights from the STABILITY trial  Conferences